| FRANK D'AMELIO | PRIME PEOPLE


ÔTalking to physicians and


understanding the market really paid off,Õ he says. ÔEllman International is a company that is over 50 years old, so having that relationship with physicians ® listening, talking and understanding what they need ® is paramount to our business. On the aesthetic side weÕ re focused on the high quality, value proposition, and weÕve found that there has been an underserved need in this area. So through smart engineering, clinical testing and market research, weÕve been able to offer great value to our physicians.Õ And it is through the acquisition of


Sandstone Medical Technologies that Ellman International can further enhance their product portfolio and successful relationship with health professionals.


ÔSandstone is a great company with a


great reputation for selling lasers, but what they needed was a bigger sales engine, and thatÕs what we could offer,Õ explains Mr DÕAmelio.


ÔWe like what they have, as well as their


proven products and approach. IÕve been involved in seven mergers and acquisitions, but we did this differently.Õ Mr DÕAmelio explained that only 4 days


after closing the deal, the entire sales force had been trained on the new laser and IPL products acquired as part of the acquisition. And then only a few days later, the sales force made their first Sandstone laser sale ® an impressive feat by anyoneÕs standards.


Quality standards It is perhaps this sharp and succinct approach to business that makes Mr DÕAmelio the right person to lead Ellman International, as well as play a leading role in the global aesthetic industry. As the industry itself is continually


evolving ® and especially in light of regulatory changes throughout Europe that will no doubt impact on a global scale ® I was keen to find out what he predicts for the future of our industry. ÔI think the industry as whole needs to


concentrate on more real science and more clinical testing,Õ he says. ÔThe industry needs high standards, high clinical efficacy and to educate. This is science ® medical science ® and we take our responsibility to educate our physicians seriously.Õ


As a medical device company we


are an extension of the physicianÕs hands so we have a serious obligation to those physicians to develop products that are worthy, and we have taken 52 years to build that reputation.


youÕ re at the helm of a company like Ellman, which took 50 years of hard work to grow and develop.Õ Mr DÕAmelio explains that in light of


recent events across Europe, it appears that perhaps some companies have lost sight of the higher standards that all should adhere to. There are many who clearly do not have a good enough


prime-journal.com | January/February 2013


As a company, Ellman International


strives to provide this for their customers, ultimately boiling down to the fact that people will buy products through companies and sales representatives they trust.


ÔI think that people need to recognise


that we are in the medical device industry, and IÕm proud of the fact that I started my career as a quality engineer and spent a lot of time as either a VP of quality or regulatory affairs,Õ Mr DÕAmelio continues.


ÔThe need to have a robust quality and


regulation system, coupled with great engineering and sales, within a company is paramount. I think thatÕs one of the things a CEO needs to recognise when


understanding of what goes into products and their development.


ÔIf you follow good manufacturing


practices and document what youÕ re doing, understand why youÕ re doing it, and ensure your products meet the latest standards,


then you have the right


appreciation for what is needed in this wonderful medical industry.Õ


Reputation Talking to Mr DÕAmelio, it is clear to see that he is a man passionate about the work he does with Ellman International, and building on the standards required in medical devices ® not just with the company he represents, but for industry as a whole.


the


ÔThis is medicine, so first do no harm.


As a medical device company we are an extension of the physicianÕs hands so we have a serious obligation to those physicians to develop products that are worthy, and we have taken 52 years to build that reputation.


ÔI want to continue bringing proven


products that work clinically, are efficacious and offer good value to physicians within the surgical and aesthetic field.Õ


❚


59


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76